Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Freddy Caldera

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Inflammatory Bowel Diseases|January 4, 2021
Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysisGursimran S Kochhar, Babu P Mohan, Shahab R Khan, et al.
The American Journal of Gastroenterology|May 8, 2024
Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B VaccinationChristian Karime, Cecily N Black, Pedro Cortes, et al.
Inflammatory Bowel Diseases|April 9, 2022
Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel DiseaseTrevor L Schell, Keith L Knutson, Sumona Saha, et al.
Vaccine|January 17, 2026
Immunogenicity and safety of a recombinant spike protein COVID vaccine in patients with inflammatory bowel disease and transplant recipientAhamed Lazim Vattoth, Mary S Hayney, Amir Masoud Forati, et al.
Clinical and Translational Gastroenterology|May 5, 2025
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor TherapyFreddy Caldera, Stacey Rolak, Francis A Farraye, et al.
Clinical and Translational Gastroenterology|February 13, 2024
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor TherapyFreddy Caldera, Stacey Rolak, Francis A Farraye, et al.
The American Journal of Gastroenterology|October 3, 2025
American College of Gastroenterology Monograph on Geriatrics and GIAdam S Faye, Sunanda V Kane, Audrey H Calderwood, et al.
Crohn'S & Colitis 360|December 22, 2023
Racial, Ethnic, and Geographic Disparities in Immunization Rates Among Patients With Inflammatory Bowel DiseasePoonam Beniwal-Patel, Gabrielle Waclawik, Keely Browning, et al.
Inflammatory Bowel Diseases|September 14, 2022
Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 VaccinationFreddy Caldera, Francis A Farraye, Brian M Necela, et al.
Inflammatory Bowel Diseases|August 26, 2021
The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)Laura E Raffals, Sumona Saha, Meenakshi Bewtra, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Inflammatory Bowel Diseases|January 4, 2021
Hepatitis-B Vaccine Response in Inflammatory Bowel Disease Patients: A Systematic Review and Meta-analysisGursimran S Kochhar, Babu P Mohan, Shahab R Khan, et al.
The American Journal of Gastroenterology|May 8, 2024
Utility of a Third Heplisav-B Dose in Patients With Inflammatory Bowel Disease Without Immunity After 2-Dose Heplisav-B VaccinationChristian Karime, Cecily N Black, Pedro Cortes, et al.
Inflammatory Bowel Diseases|April 9, 2022
Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel DiseaseTrevor L Schell, Keith L Knutson, Sumona Saha, et al.
Vaccine|January 17, 2026
Immunogenicity and safety of a recombinant spike protein COVID vaccine in patients with inflammatory bowel disease and transplant recipientAhamed Lazim Vattoth, Mary S Hayney, Amir Masoud Forati, et al.
Clinical and Translational Gastroenterology|May 5, 2025
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor TherapyFreddy Caldera, Stacey Rolak, Francis A Farraye, et al.
Clinical and Translational Gastroenterology|February 13, 2024
Higher and Sustained Cell-Mediated Immune Responses After 3 Doses of mRNA COVID-19 Vaccine in Patients With Inflammatory Bowel Disease on Anti-Tumor Necrosis Factor TherapyFreddy Caldera, Stacey Rolak, Francis A Farraye, et al.
The American Journal of Gastroenterology|October 3, 2025
American College of Gastroenterology Monograph on Geriatrics and GIAdam S Faye, Sunanda V Kane, Audrey H Calderwood, et al.
Crohn'S & Colitis 360|December 22, 2023
Racial, Ethnic, and Geographic Disparities in Immunization Rates Among Patients With Inflammatory Bowel DiseasePoonam Beniwal-Patel, Gabrielle Waclawik, Keely Browning, et al.
Inflammatory Bowel Diseases|September 14, 2022
Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 VaccinationFreddy Caldera, Francis A Farraye, Brian M Necela, et al.
Inflammatory Bowel Diseases|August 26, 2021
The Development and Initial Findings of A Study of a Prospective Adult Research Cohort with Inflammatory Bowel Disease (SPARC IBD)Laura E Raffals, Sumona Saha, Meenakshi Bewtra, et al.
Pageof 13